DK449888A - Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret - Google Patents

Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret

Info

Publication number
DK449888A
DK449888A DK449888A DK449888A DK449888A DK 449888 A DK449888 A DK 449888A DK 449888 A DK449888 A DK 449888A DK 449888 A DK449888 A DK 449888A DK 449888 A DK449888 A DK 449888A
Authority
DK
Denmark
Prior art keywords
various
dsrna
responsibility
immune
enhances
Prior art date
Application number
DK449888A
Other languages
Danish (da)
English (en)
Other versions
DK449888D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK449888D0 publication Critical patent/DK449888D0/da
Publication of DK449888A publication Critical patent/DK449888A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK449888A 1987-08-12 1988-08-11 Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret DK449888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
DK449888D0 DK449888D0 (da) 1988-08-11
DK449888A true DK449888A (da) 1989-02-13

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK449888A DK449888A (da) 1987-08-12 1988-08-11 Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret

Country Status (19)

Country Link
EP (1) EP0308066B1 (de)
JP (1) JPH01131119A (de)
KR (1) KR0131879B1 (de)
CN (1) CN1050995C (de)
AT (1) ATE132041T1 (de)
AU (3) AU2053588A (de)
CA (1) CA1327002C (de)
DE (1) DE3854829T2 (de)
DK (1) DK449888A (de)
FI (1) FI883763A (de)
HU (1) HUT47854A (de)
IE (1) IE72103B1 (de)
IL (1) IL87413A0 (de)
NO (1) NO883594L (de)
NZ (1) NZ225799A (de)
OA (1) OA08901A (de)
PT (1) PT88266B (de)
RU (1) RU1834663C (de)
ZA (1) ZA885967B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (de) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnose von Mangelzuständen doppelsträngiger RNS
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
JP3256222B2 (ja) * 1989-10-16 2002-02-12 エイチイーエム リサーチ，インコーポレイティド 全身性免疫機能不全に関連する神経―知覚疾患の診断及び治療
EP0654998A1 (de) * 1991-09-26 1995-05-31 Hem Pharmaceuticals Corp. Verfahren zur neutralisierung von il-1 unter verwendung von doppelsträngiger rna
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
EP1229134A3 (de) 2001-01-31 2004-01-28 Nucleonics, Inc Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
ES2397060T3 (es) * 2002-04-18 2013-03-04 Opko Pharmaceuticals, Llc Medios y métodos para la modulación específica de genes diana en el ojo
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
EP1551424B1 (de) 2002-09-04 2015-07-01 Arrowhead Research Corporation Behandlung von chronisch neuropathischen schmerzen durch verabreichung von dsrna
EP2134172A4 (de) * 2007-03-05 2011-06-01 Univ Utah State Restriktiver agonist des toll-like-rezeptors 3
US8470792B2 (en) 2008-12-04 2013-06-25 Opko Pharmaceuticals, Llc. Compositions and methods for selective inhibition of VEGF
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
EP0308066B1 (de) 1995-12-27
PT88266A (pt) 1989-06-30
AU2053588A (en) 1989-04-20
NZ225799A (en) 1991-04-26
IL87413A0 (en) 1989-01-31
AU1001595A (en) 1995-02-23
DK449888D0 (da) 1988-08-11
KR890003402A (ko) 1989-04-14
EP0308066A3 (de) 1991-01-16
JPH01131119A (ja) 1989-05-24
CN1032740A (zh) 1989-05-10
IE72103B1 (en) 1997-03-12
FI883763A (fi) 1989-02-13
RU1834663C (ru) 1993-08-15
ZA885967B (en) 1989-07-26
IE882399L (en) 1989-02-12
HUT47854A (en) 1989-04-28
CA1327002C (en) 1994-02-15
FI883763A0 (fi) 1988-08-12
DE3854829T2 (de) 1996-08-14
NO883594D0 (no) 1988-08-12
EP0308066A2 (de) 1989-03-22
ATE132041T1 (de) 1996-01-15
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
AU1736792A (en) 1992-07-30
NO883594L (no) 1989-02-13
CN1050995C (zh) 2000-04-05
DE3854829D1 (de) 1996-02-08
PT88266B (pt) 1995-05-04

Similar Documents

Publication Publication Date Title
DK449888D0 (da) Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
DK345484A (da) Projektil til ildvaaben
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
DE69030202D1 (de) Phenylalkan(en)-Säuren mit Leukotrien B4 antagonistischer Wirkung
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
NO880934L (no) Fremgangsmaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
DK0587554T3 (da) Podofyllotoksinpræparat indeholdende triglycerider
Balvay et al. Long-term quantitative evolution of rotifers during the eutrophication in Lake Geneva.
JPS5356390A (en) Preparation of d-ribose-5'-phosphoric acid derivatives
ES2014290B3 (es) Uso de acidos 7-cloroquinolina, 8-carbono para influir en el desarrollo de plantas de cultivo.
USD133969S (en) Design fob ultraviolet lamp
USD141371S (en) Design fob a wall switch plate
USD203904S (en) List finder
Establier On the contamination and biological effects of mercury).
Chizhov Evaluation of the Inhibiting Effect of Virazole on Vaccinia Virus Reproduction in Tissue Culture.
Moutou Biogeographical approach to a disease. Example: Rabies.).
Jaime E. Rodríguez O. Stephen F. Austin: Empresario of Texas
Sampley The Betrayers
Horsch et al. Infectious factorial diseases of farm animals.
JPS5529941A (en) Preparation of pyrimidine arabinosides
DE3861012D1 (de) Ofen, insbesondere zur verbrennung fester brennstoffe.
AU4849897A (en) Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment